Advertisement
U.S. markets open in 3 hours 2 minutes
  • S&P Futures

    5,206.50
    -8.25 (-0.16%)
     
  • Dow Futures

    39,192.00
    -31.00 (-0.08%)
     
  • Nasdaq Futures

    18,189.25
    -42.25 (-0.23%)
     
  • Russell 2000 Futures

    2,045.40
    -4.40 (-0.21%)
     
  • Crude Oil

    82.43
    -0.29 (-0.35%)
     
  • Gold

    2,158.70
    -5.60 (-0.26%)
     
  • Silver

    25.13
    -0.14 (-0.53%)
     
  • EUR/USD

    1.0846
    -0.0031 (-0.28%)
     
  • 10-Yr Bond

    4.3400
    0.0000 (0.00%)
     
  • Vix

    14.60
    +0.27 (+1.88%)
     
  • GBP/USD

    1.2682
    -0.0047 (-0.37%)
     
  • USD/JPY

    150.5280
    +1.4300 (+0.96%)
     
  • Bitcoin USD

    63,187.55
    -4,682.57 (-6.90%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,721.67
    -0.88 (-0.01%)
     
  • Nikkei 225

    40,003.60
    +263.20 (+0.66%)
     

Equities Driven By Market Influences - Research on Huttig Building Products, Pain Therapeutics, Dixie Group and Cerulean Pharma

NEW YORK, NY / ACCESSWIRE / December 2, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Huttig Building Products Inc (HBP), Pain Therapeutics Inc (PTIE), Dixie Group Inc (DXYN) and Cerulean Pharma Inc (CERU). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

HBP Research Package: http://www.traders-choice.com/pdf?s=HBP

PTIE Research Package: http://www.traders-choice.com/pdf?s=PTIE

DXYN Research Package: http://www.traders-choice.com/pdf?s=DXYN

CERU Research Package: http://www.traders-choice.com/pdf?s=CERU

============

Highlights from today's reports include:

On Tuesday, December 01, 2015, the NASDAQ Composite ended at 5,156.31, up 0.93%, the Dow Jones Industrial Average advanced 0.95%, to finish the day at 17,888.35, and the S&P 500 closed at 2,102.63, up 1.07%.

- The stock of Huttig Building Products Inc lost 0.27% to close Tuesday's session at USD 3.69. The shares of the company moved in the range of USD 3.64 and USD 3.70. A trading volume of 0.01 million shares was recorded, which was almost same as its 150-day daily average volume and 52-week average volume of 0.01 million shares each. Over the last five days, Huttig Building Products Inc's shares have advanced 5.43% and in the past one month, it has gained a momentum of 3.95%. Additionally, over the last three months, the stock has advanced 17.52% and in the past six months, the shares have registered a profit of 8.53%. Further, the company is trading at a price to earnings ratio of 3.13 and at a price to book ratio of 3.27. This compares to a historical PE ratio of 13.57. The historical PB ratio is near to 3.20. Further, the stock is trading at a price to cash flow ratio of 8.90 and price to sales ratio of 0.14.

- Pain Therapeutics Inc's stock declined by 1.50% to close Tuesday's session at USD 1.97. The company's shares fluctuated in the range of USD 1.90 and USD 2.00. The 52-week low for the stock is USD 1.53 and the 52-week high is USD 3.65. A total of 0.06 million shares exchanged hands, which was lesser than its 50-day daily average volume of 0.09 million shares and was below its 52-week average volume of 0.32 million shares. Over the last three days Pain Therapeutics Inc's shares have advanced 1.55% and in the past one week it has moved up 2.60%. Furthermore, over the last three months, the stock has gained 10.06% and in the past six months, the shares have picked up 1.55%. The stock is at a price to book ratio of 2.77. The historical PB ratio is near to 2.32.

- Dixie Group Inc's stock slipped by 0.18% to close Tuesday's session at USD 5.63. The company's shares oscillated between USD 5.48 and USD 5.68. The stock recorded a trading volume of 0.12 million shares, which was above its 50-day daily average volume of 0.09 million shares. Over the last five days, Dixie Group Inc's shares have advanced 2.18% while in the past one month, it has lost 15.97%. Over the last three months, the stock has lost 42.37% and year to date, the shares have shed 38.60%. The stock is at a price to book ratio of 1.00. The historical PB ratio is near to 1.52. Additionally, the stock is trading at a price to cash flow ratio of 12.00 and price to sales ratio of 0.20. The company has a market cap of USD 94.42 million.

- Cerulean Pharma Inc's stock advanced 1.54% to close Tuesday's session at USD 3.29. The share price vacillated between USD 3.24 and USD 3.44. The stock recorded a trading volume of 0.02 million shares, which was below its 50-day daily average volume of 0.07 million shares and below its 52-week average volume of 0.11 million shares. Over the last three days Cerulean Pharma Inc's shares have declined by 2.08% while in the past one week it has moved up 0.30%. The stock has a 52-week low of USD 2.77 and a 52-week high of USD 10.87. The company has a market cap of USD 89.97 million. The shares are trading below their 50-day and 200-day moving averages of USD 3.44 and USD 4.19, respectively.

About Trader's Choice:

Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com

SOURCE: Trader's Choice

Advertisement